Overview A Dose-Finding, Efficacy and Safety Study of YY-351 in Patients With Type 2 Diabetes Status: Completed Trial end date: 2009-06-01 Target enrollment: Participant gender: Summary The purpose of this trial is to determine the dosage selected and to evaluate the efficacy and safety of YY-351. Phase: Phase 2 Details Lead Sponsor: Yuyu Pharma, Inc.